03:35 AM EDT, 05/16/2024 (MT Newswires) -- Leonard S Schleifer, Director, Board Co-Chair, President & Chief Executive Officer, on May 13, 2024, sold 35,941 shares in Regeneron Pharmaceuticals ( REGN ) for $35,207,110. Following the Form 4 filing with the SEC, Schleifer has control over a total of 718,176 shares of the company, with 397,259 shares held directly and 320,917 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000188385024000022/xslF345X03/edgardoc.xml

Price: 977.30, Change: -0.91, Percent Change: -0.09